-
1.
公开(公告)号:WO2013142124A1
公开(公告)日:2013-09-26
申请号:PCT/US2013030267
申请日:2013-03-11
Applicant: VERTEX PHARMA
Inventor: KULDIPKUMAR ANUJ K , MEDEK ALES , FERRIS LORI ANN , MUDUNURI PRAVEEN , JUNG YOUNG CHUN , WILLCOX DAVID RICHARD , WALDO MICHAEL , NUGENT WILLIAM ALOYSIUS
IPC: C07H19/06 , A61K31/7072 , A61P31/14
CPC classification number: C07H19/10 , A61K31/7056 , A61K31/706 , A61K31/7064 , A61K31/7068 , A61K31/7072 , A61K38/00 , A61K45/06 , C07B2200/13 , C07H19/06 , A61K2300/00
Abstract: The present application relates to solid state forms, for example, crystalline forms of 2'- C-methyluridine-5 '-(O-phenyl-N-(S)- 1 -(isopropoxycarbonyl)ethyl)thiophosphoramidate, pharmaceutical compositions that can include one or more solid forms of 2'-C-methyluridine-5'- (0-phenyl-N-(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, and methods of treating or ameliorating diseases and/or conditions with one or more solid forms of 2'-C-methyluridine-5'- (O-phenyl-N-(S)- 1 -(isopropoxy carbonyl)ethyl)thiophosphoramidate. Also disclosed herein are methods of treating diseases and/or conditions with one or more solid forms of 2'-C- methyluridine-5 '-(O-phenyl-N-(S)- 1 -(isopropoxycarbonyl)ethyl)thiophosphoramidate in combination with one or more other agents.
Abstract translation: 本申请涉及固体形式,例如2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺的结晶形式,可以包括 一种或多种固体形式的2'-C-甲基尿苷-5'-(O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代氨基磷酸酯,以及用一种或多种硫代磷酸酰胺酯治疗或改善疾病和/或病症的方法 更多固体形式的2'-C-甲基尿苷-5'-(O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺。 本文还公开的是使用一种或多种固体形式的2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺的组合治疗疾病和/或病症的方法 与一个或多个其他代理。
-
公开(公告)号:DK3068782T3
公开(公告)日:2018-08-13
申请号:DK14802788
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/04 , C07C51/083
-
公开(公告)号:DK3421468T3
公开(公告)日:2021-01-11
申请号:DK18164040
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/04 , C07C51/083
-
公开(公告)号:PL3068782T3
公开(公告)日:2018-12-31
申请号:PL14802788
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/04 , C07C51/083
-
公开(公告)号:RS57541B1
公开(公告)日:2018-10-31
申请号:RSP20180952
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/04 , C07C51/083
-
公开(公告)号:AU2014348752A1
公开(公告)日:2016-05-26
申请号:AU2014348752
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/04 , C07C51/083
Abstract: A method of preparing Compound (1) or a pharmaceutically acceptable salt thereof: comprises: (a) reacting Compound (X): a pharmaceutically acceptable salt thereof with Compound (Y): in the presence of a palladium catalyst and a carbonate or phosphate base to form compound (Z): or a pharmaceutically acceptable salt thereof; and (b) deprotecting the Ts group of Compound (Z) to form Compound (1) or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:CY1121074T1
公开(公告)日:2019-12-11
申请号:CY181100876
申请日:2018-08-22
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/04 , C07C51/083
Abstract: ΜέθοδοςπαρασκευήςτηςΈνωσης (1) ήενόςφαρμακευτικώςαποδεκτούάλατοςαυτής: περιλαμβάνει: (α) αντίδρασητηςΈνωσης (Χ): ενόςφαρμακευτικώςαποδεκτούάλατοςαυτήςμετηνΈνωση (Υ): υπότηνπαρουσίαενόςκαταλύτηπαλλαδίουκαιμιαςανθρακικήςή φωσφορικήςβάσηςγιατονσχηματισμότηςΈνωσης (Ζ): ήενόςφαρμακευτικώςαποδεκτούάλατοςαυτής, και (β) αποπροστασίατης Ts ομάδαςτηςΈνωσης (Ζ) γιανασχηματιστείη Ένωση (1) ήέναφαρμακευτικώςαποδεκτόάλαςαυτής.
-
公开(公告)号:SI3068782T1
公开(公告)日:2018-10-30
申请号:SI201430850
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/00 , C07C51/00
-
公开(公告)号:SI3421468T1
公开(公告)日:2021-03-31
申请号:SI201431743
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/00 , C07C51/00
-
公开(公告)号:HRP20210029T1
公开(公告)日:2021-03-19
申请号:HRP20210029
申请日:2021-01-08
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , NUGENT WILLIAM ALOYSIUS , DVORNIKOVS VADIMS , ROSE PETER JAMISON
IPC: C07D471/04 , C07C51/083
-
-
-
-
-
-
-
-
-